{{Rsnum
|rsid=2980003
|Chromosome=8
|position=65087728
|Orientation=minus
|GMAF=0.2897
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.4 | 37.0 | 55.6
| HCB | 20.0 | 46.7 | 33.3
| JPT | 18.2 | 52.3 | 29.5
| YRI | 4.2 | 24.6 | 71.1
| ASW | 7.3 | 40.0 | 52.7
| CHB | 20.0 | 46.7 | 33.3
| CHD | 11.3 | 46.2 | 42.5
| GIH | 9.1 | 41.4 | 49.5
| LWK | 6.7 | 26.7 | 66.7
| MEX | 10.5 | 54.4 | 35.1
| MKK | 0.0 | 0.0 | 0.0
| TSI | 3.1 | 49.0 | 48.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=T
  |Pval=5E-6
  |OR=22.07
  |ORtxt=[12.6-31.54] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}